News | MRI Breast | May 09, 2019

Study finds short-interval follow-up MRI may be appropriate for high-risk patients

Screening MRI Detects BI-RADS 3 Breast Cancer in High-risk Patients

May 9, 2019 — When appropriate, short-interval follow-up magnetic resonance imaging (MRI) can be used to identify early-stage breast cancer and avoid unnecessary biopsies, according to a new study. The findings were presented at the American Roentgen Ray Society (ARRS) 2019 Annual Meeting, May 5-10 in Honolulu.

Utilization of MRI for breast cancer screening continues to increase, as it is the most sensitive modality to detect breast cancer. Yet, much more is known about short-term follow-up of probably benign findings (<2 percent of malignancy) for mammography than MRI. The study was conducted to evaluate the frequency and cancer yield of American College of Radiology (ACR) Breast Imaging Reporting and Data System (BI-RADS) 3 lesions in patients undergoing baseline versus non-baseline high-risk screening MRI exams. Non-baseline MRI screening exams were defined as those preceded by at least one screening exam.

Among the 6,672 MRI screening exams performed in 3,214 patients included in the study, 202 (3 percent) were assigned a BI-RADS 3. Among baseline exams, 8.3 percent (82/983) were assigned BI-RADS 3, compared to 2.1 percent (120/5689) of non-baseline exams (p<0.01). Thirteen of 202 (6.4 percent) of the total BI-RADS 3 lesions yielded malignancy, with 12 of the 13 cancers described as either stage 0 or I at diagnosis. Out of 82 baseline exams, the cancer yield of BI-RADS 3 was 2 (2.4 percent), versus 11 of 120 (9.2 percent) on non-baseline exams (p=0.056). Of the 13 diagnosed cancers, eight were initially characterized as foci, three as non-mass enhancement and two as masses. Ten of 13 cancers were upgraded at the six-month follow-up MRI or before.

The results indicate BI-RADS 3 assessments are significantly more common in baseline versus non-baseline screening breast MRI exams, and BI-RADS 3 lesions on baseline exams have a lower cancer yield. Most cancers diagnosed on follow-up of BI-RADS 3 lesions are early stage and most are diagnosed at or before the six-month follow-up. The results indicate that when employed sensibly, short-interval follow-up MRI is an appropriate technique to identify early-stage breast cancer. "This study clarifies that probably benign assessments can be as useful for MRI as they are for mammography," said co-author Leslie Lamb, M.D., MSc, of Massachusetts General Hospital (MGH) and Harvard Medical School, both in Boston.

"Many patients and providers question the utility of BI-RADS 3 in MRI, particularly as some insurers do not cover the costs of the short interval follow-up MRIs. This study clarifies that short interval follow-up MRI is a valuable method of identifying early stage breast cancer while avoiding unnecessary biopsies." noted co-author Christine Edmonds, M.D., of the department of radiology at MGH.

For more information: www.arrs.org

 

Related Dense Breast Content:

Breast Density Explained

Animation to Bring Clarity to Dense Breasts

Improving Clinical Image Quality for Breast Imaging

Breast Imaging in the Age of Coronavirus

Abbreviated MRI Outperforms 3-D Mammograms at Finding Cancer in Dense Breasts

VIDEO: Use of Breast MRI Improved Cancer Detection in Dense Breasts in Dutch Study — Interview with Gillian Newstead, M.D.

Technologies to Watch in Breast Imaging

Related Content

News | Ultrasound Women's Health

May 16, 2022 — The Barcelona Supercomputing Center (BSC) coordinates QUSTom (Quantitative Ultrasound Stochastic ...

Time May 16, 2022
arrow
News | Breast Imaging

May 16, 2022 — iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy ...

Time May 16, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

May 13, 2022 — Alzheimer’s disease is the most common form of dementia, one of the major causes of dependency and ...

Time May 13, 2022
arrow
News | Contrast Media

May 13, 2022 — The ACR Committee on Drugs and Contrast Media, within the ACR Commission on Quality and Safety, is aware ...

Time May 13, 2022
arrow
News | Radiology Business

May 12, 2022 — Abbott announced a new partnership with Women as One to launch a new program designed to train more ...

Time May 12, 2022
arrow
News | Women's Health

May 12, 2022 — Volpara Health will showcase new and updated products for its integrated platform for the delivery of ...

Time May 12, 2022
arrow
News | Radiology Education

May 11, 2022 — DetectedX announced that it will launch its Radiology Online Learning Platform to radiologists in the ...

Time May 11, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

May 10, 2022 — At the ISMRM 2022 conference, Bruker announced the launch of innovative 7 Tesla and 9.4 Tesla conduction ...

Time May 10, 2022
arrow
News | Radiation Therapy

May 10, 2022 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides guidance on ...

Time May 10, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

May 9, 2022 — At the International Society for Magnetic Resonance in Medicine (ISMRM) 2022 Annual Meeting, GE Healthcare ...

Time May 09, 2022
arrow
Subscribe Now